| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss from continuing operations (include gain on disposal of subsidiary) | -132,890 | -145,888 |
| Depreciation and amortization expense | 176 | 118 |
| Operating lease expense | 34,746 | 25,346 |
| Accounts receivable | -155 | -155 |
| Prepaid expenses and other receivables | -187,796 | -187,794 |
| Prepayment and deposits | 64,265 | 21,104 |
| Accounts payable | -7,131 | -7,046 |
| Customer deposit | 642,524 | 103,164 |
| Tax payable | -316 | 494 |
| Accrued liability and other payables | -336,302 | - |
| Other current liability | 4,208 | -1,305 |
| Loss on disposal of fixed assets | 0 | 0 |
| Gain from disposal of discontinued operations | 0 | 0 |
| Impairment loss of rou asset | 0 | - |
| Receivable from sale of bep | 0 | - |
| Accrued interest | 0 | 0 |
| Payment of lease liability | 0 | 0 |
| Net cash provided by operating activities from continuing operations | 328,701 | 141,728 |
| Net cash used in operating activities from discontinued operations | 0 | 0 |
| Net cash provided by operating activities | 328,701 | 141,728 |
| Loan from shareholder | 643,450 | 419,400 |
| Repayment to shareholder | -943,800 | -568,800 |
| Repayment of sba loan | 981 | 665 |
| Change in bank overdraft | 0 | 6,966 |
| Net cash used in financing activities from continuing operations | -301,331 | -143,099 |
| Net cash used in financing activities from discontinued operations | 0 | 0 |
| Net cash used in financing activities | -301,331 | -143,099 |
| Net increase in cash | 27,370 | -1,371 |
| Cash and cash equivalents at beginning of period | 1,371 | - |
| Cash and cash equivalents at end of period | 28,741 | - |
Bio Essence Corp (BIOE)
Bio Essence Corp (BIOE)